PHILADELPHIA — (November 19, 2024) — A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential i…
PHILADELPHIA — (NOV. 14, 2024) — The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center was the recipient of a $100,000 eXperience grant from NIIMBL to support an immersive wee…
PHILADELPHIA — (October 22, 2024) —President and CEO of The Wistar Institute Dario Altieri, M.D., has been appointed to the Board of Directors of the Chamber of Commerce for Greater Philadelphia. T…
PHILADELPHIA — (October 11, 2024) — In the latest issue of The Philadelphia Business Journal, The Wistar Institute’s Maureen Murphy, Ph.D. — Deputy Director of the Ellen and Ronald Caplan Cancer Ce…
PHILADELPHIA — (Oct. 8, 2024) — New research from The Wistar Institute’s Salvino lab — led by professor Joseph Salvino, Ph.D. — has identified a novel series of SARS-CoV-2 Mpro inhibitors that may …
PHILADELPHIA — (September 17th, 2024) — The Wistar Institute’s President and CEO, Dario C. Altieri, M.D., and team have demonstrated the role of Parkin — a protein implicated in Parkinson’s disease…
PHILADELPHIA, PA – August 13, 2024 – The Wistar Institute and Wexford Science & Technology, LLC announced that Wistar has signed a lease for new laboratory and office space at uCity Square in Phila…
